Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.

† Those without notes are either nonspecific or give too many clues of the diseases that cannot be listed. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; FDG PET-CT ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...